Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Psychosis

Study Links High-Potency Cannabis to Epigenetic Changes in DNA

A recent study from King’s College London published in Molecular Psychiatry reveals that high-potency cannabis, particularly with THC levels of 10% or more, induces significant epigenetic changes in DNA. This research highlights the potential mental health implications of cannabis use, especially in individuals experiencing their first episode of psychosis. The findings suggest a unique DNA signature linked to high-potency cannabis, paving the way for future studies on its genetic impact and potential risk assessment for psychosis.

Study Links Adolescent Migration to Increased Risk of Psychosis

Recent research links adolescent migration to an increased risk of psychosis, particularly among black and North African migrants. Led by Professor James Kirkbride at UCL, the study highlights the mental health challenges faced by young migrants during critical developmental years. Findings reveal that those migrating between ages 11 and 17 are nearly twice as likely to develop psychosis. This underscores the urgent need for targeted mental health support for adolescent migrants as they navigate new environments.

Groundbreaking Schizophrenia Drug KarXT Receives US Approval

A groundbreaking schizophrenia medication, KarXT, has received US approval, marking a significant advancement in psychiatric treatment. This innovative drug targets muscarinic receptors, effectively reducing dopamine release and alleviating core symptoms like hallucinations and delusions. With fewer side effects than traditional antipsychotics, KarXT promises a new era of tailored therapies for individuals suffering from schizophrenia, enhancing cognitive function and improving quality of life.

Study Links Teen Cannabis Use to Higher Risk of Psychotic Disorders

A recent study reveals an alarming 11 times higher risk of psychotic disorders in teenagers who use cannabis compared to non-users. The study, analyzing data from over 11,000 young individuals in Ontario, Canada, highlights the potential impact of cannabis use on mental health, especially with the rise in THC potency levels. Lead author Dr. André McDonald emphasizes the strong association between cannabis use and psychotic disorders in adolescence, urging further consideration of the risks involved.

Senua’s Saga: Hellblade II Continues to Impress with Stunning Graphics and Authentic Mental Health Portrayal

Senua’s Saga: Hellblade II, the highly anticipated sequel by Ninja Theory, promises to delve deeper into the inner struggles of protagonist Senua, offering players a unique insight into her battle with inner and outer demons. With enhanced graphics and a focus on portraying mental illness authentically, the game aims to immerse players in Senua’s complex world. Set to launch on May 21 for PC and Xbox Series S/X, Senua’s Saga: Hellblade II will be available on Game Pass from day one, providing easy access to this captivating and immersive gaming experience.

Antipsychotic Use in Dementia Linked to Adverse Outcomes, Study Finds

A recent study published in The BMJ reveals the increased risks faced by adults with dementia who use antipsychotic medications. The research conducted by Dr. Pearl LH Mok and colleagues found that antipsychotic use in this population was linked to a higher risk of serious conditions such as stroke, heart failure, and pneumonia. Healthcare providers and caregivers are urged to carefully weigh the potential risks and benefits of antipsychotic medications in individuals with dementia.

Study Finds Weak Link Between Adolescent Media Use and Psychotic Experiences in Adulthood

A study from McGill University found weak associations between adolescent media use and psychotic experiences in adulthood, with other factors such as mental health and interpersonal difficulties playing a larger role. The lead author, Vincent Paquin, stated that the results do not support the idea that adolescent media use is a significant risk factor for psychotic experiences in adulthood. The study suggests that some young people are drawn to video games as a way of coping with challenging life circumstances.

The Untold Story of Jake Lloyd: Life After ‘The Phantom Menace’

As the 25th anniversary of ‘Star Wars Episode I: The Phantom Menace’ approaches, the absence of Jake Lloyd, who played Anakin Skywalker, from recent celebrations has raised questions. In an exclusive interview, his mother, Lisa Lloyd, shares Jake’s struggles with mental illness and family tragedy, shedding light on his tumultuous journey since his role in the iconic film.